{"accession":"BGC0002075","version":3,"changelog":{"releases":[{"version":"1","entries":[{"contributors":["6CADHILFODRMCII55WHSHZ6V"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-09-15","comment":"Submitted"},{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-09-15","comment":"Corrected NRP module activity"},{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-09-15","comment":"Removed gene names of 'No gene ID'"},{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-09-15","comment":"Added version to NCBI accession"},{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-09-15","comment":"Updated NRP substrate specificities"}],"date":"2022-09-15"},{"version":"2","entries":[{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-10-07","comment":"Update chemical activity to schema version 2.11"},{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-10-07","comment":"Changed chemical structures for compounds: pyreudione E, pyreudione B, pyreudione D."}],"date":"2022-10-07"},{"version":"3","entries":[{"contributors":["6CADHILFODRMCII55WHSHZ6V","MGLE5JJ3S32DQA3YR5WPYH4W"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2024-06-04","comment":"MIBiG v4 annotathon"}],"date":"2024-11-15"}]},"quality":"questionable","status":"active","completeness":"complete","loci":[{"accession":"NZ_LVEJ01000014.1","location":{"from":27345,"to":31238},"evidence":[{"method":"Knock-out studies"},{"method":"Enzymatic assays"},{"method":"Heterologous expression"}]}],"biosynthesis":{"classes":[{"class":"NRPS","subclass":"Type I","release_types":[{"name":"Other","references":["doi:10.1002/anie.201603312","doi:10.1016/j.chembiol.2018.02.013"],"details":"Dieckmann-type cyclization"}],"thioesterases":[{"type":"thioesterase","gene":"WP_064118616.1","location":{"from":1042,"to":1265},"subtype":"Type I"}]}],"modules":[{"type":"nrps-type1","name":"pys","genes":["A8O26_RS14270"],"active":true,"carriers":[{"type":"carrier","gene":"WP_064118616.1","location":{"from":954,"to":1023},"subtype":"PCP","beta_branching":false}],"a_domain":{"type":"adenylation","gene":"WP_064118616.1","location":{"from":463,"to":849},"references":["doi:10.1016/j.chembiol.2018.02.013"],"substrates":[{"name":"proline","structure":"N1C(CCC1)C(=O)O","proteinogenic":true},{"name":"pipecolic acid","structure":"N1C(CCCC1)C(=O)O","proteinogenic":false},{"name":"4-hydroxyproline","structure":"O=C(O)[C@]1([H])NC[C@@H](O)C1","proteinogenic":false},{"name":"4-oxoproline","structure":"O=C(O)[C@]([H])(C1)NCC1=O","proteinogenic":false},{"name":"azetidine-2-carboxylic acid","structure":"OC(C1NCC1)=O","proteinogenic":false}],"evidence":[{"method":"ATP-PPi exchange assay","references":["doi:10.1016/j.chembiol.2018.02.013"]}],"inactive":false},"c_domain":{"type":"condensation","gene":"WP_064118616.1","location":{"from":6,"to":303},"subtype":"Starter","references":["doi:10.1002/anie.201603312","doi:10.1016/j.chembiol.2018.02.013"]}}],"operons":[{"genes":["A8O26_RS14270"],"evidence":[]}],"paths":[{"products":[{"name":"pyreudione A","structure":"O/C(CCCCCCC)=C(C(N1[C@]2(CCC1)[H])=O)/C2=O","comment":"The single NRPS is multispecific with regards to amino acid activation (L-proline, L-pipecolic acid) and C starter domain substrate specificity (3-oxo fatty acids of different length and saturation), thereby allowing to form different tetramic acids via Dieckmann-type cyclization. Depending on the amino acid substrate, acyltetramic acids with a pyrrolizidine (A domain substrate: L-proline) or an indolicidine (A domain substrate: L-pipecolic acid) core structure are formed. Product if saturated C10 fatty acid is condensed to L-proline"},{"name":"pyreudione B","structure":"O/C(CCCCCCCCC)=C(C(N1[C@]2(CCC1)[H])=O)/C2=O","comment":"Product if saturated C12 fatty acid is condensed to L-proline"},{"name":"pyreudione C","structure":"OC(/C=C/CCCCCCC)=C(C(N1[C@]2(CCC1)[H])=O)/C2=O","comment":"Product if unsaturated C12 fatty acid is condensed to L-proline"},{"name":"pyreudione D","structure":"O/C(CCC/C=C\\CCCCCC)=C(C(N1[C@]2(CCC1)[H])=O)/C2=O","comment":"Product if unsaturated C14 fatty acid is condensed to L-proline"},{"name":"pyreudione E","structure":"O/C(CCCCCCC)=C(C(N1[C@]2(CCCC1)[H])=O)/C2=O","comment":"Product if L-pipecolic acid is activated by the A-domain and condensed with saturated C10 fatty acid"}],"steps":"pys","references":["doi:10.1002/anie.201603312","doi:10.1016/j.chembiol.2018.02.013"],"isSubcluster":false,"producesPrecursor":false}]},"compounds":[{"name":"pyreudione A","evidence":[{"method":"NMR","references":["doi:10.1002/anie.201603312"]},{"method":"Mass spectrometry","references":["doi:10.1002/anie.201603312"]},{"method":"Total synthesis","references":["doi:10.1002/anie.201603312"]}],"classes":["Proline-derived","Tetramate alkaloid"],"bioactivities":[{"name":"antibacterial","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"25.0 µg/mL","target":"antibacterial"}]},{"name":"cytotoxic","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"28.0 µg/mL","target":"cytotoxic"}]},{"name":"antiprotozoal","observed":true,"references":["doi:10.1002/anie.201603312"],"assays":[{"concentration":"11.0 µg/mL","target":"antiprotozoal"}]}],"structure":"O=C([C@@]1([H])N(C/2=O)CCC1)C2=C(O)/CCCCCCC","databaseIds":["npatlas:NPA024339","chebi:219377","pubchem:139591486"],"moieties":["alkyl side chain","Pyrrolizidine dione"],"cyclic":true,"mass":265.16779,"formula":"C15H23NO3"},{"name":"pyreudione B","evidence":[{"method":"NMR","references":["doi:10.1002/anie.201603312"]},{"method":"Total synthesis","references":["doi:10.1002/anie.201603312"]},{"method":"Mass spectrometry","references":["doi:10.1002/anie.201603312"]}],"classes":["Proline-derived","Tetramate alkaloid"],"bioactivities":[{"name":"antibacterial","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"3.12 µg/mL","target":"antibacterial"}]},{"name":"cytotoxic","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"24.0 µg/mL","target":"cytotoxic"}]},{"name":"antiprotozoal","observed":true,"references":["doi:10.1002/anie.201603312"],"assays":[{"concentration":"2.0 µg/mL","target":"antiprotozoal"}]}],"structure":"O/C(CCCCCCCCC)=C(C(N1[C@@]2([H])CCC1)=O)/C2=O","databaseIds":["chebi:219383","npatlas:NPA024340","pubchem:139591487"],"moieties":["alkyl side chain","Pyrrolizidine dione"],"cyclic":true,"mass":293.19909,"formula":"C17H27NO3"},{"name":"pyreudione C","evidence":[{"method":"NMR","references":["doi:10.1002/anie.201603312"]},{"method":"Mass spectrometry","references":["doi:10.1002/anie.201603312"]}],"classes":["Proline-derived","Tetramate alkaloid"],"bioactivities":[{"name":"antibacterial","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"1.56 µg/mL","target":"antibacterial"}]},{"name":"cytotoxic","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"13.0 µg/mL","target":"cytotoxic"}]},{"name":"antiprotozoal","observed":true,"references":["doi:10.1002/anie.201603312","doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"1.0 µg/mL","target":"antiprotozoal"}]}],"structure":"CCCCCCC/C=C/C(=C/1\\C(=O)[C@@H]2CCCN2C1=O)/O","databaseIds":["chebi:219389","pubchem:139591488","npatlas:NPA024341"],"moieties":["alkyl side chain","Pyrrolizidine dione"],"cyclic":true,"mass":291.18344,"formula":"C17H25NO3"},{"name":"pyreudione D","evidence":[{"method":"NMR","references":["doi:10.1002/anie.201603312"]},{"method":"Mass spectrometry","references":["doi:10.1002/anie.201603312"]}],"classes":["Proline-derived","Tetramate alkaloid"],"bioactivities":[{"name":"antibacterial","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"0.78 µg/mL","target":"antibacterial"}]},{"name":"cytotoxic","observed":true,"references":["doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"50.0 µg/mL","target":"cytotoxic"}]},{"name":"antiprotozoal","observed":true,"references":["doi:10.1002/anie.201603312","doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"5.0 µg/mL","target":"antiprotozoal"}]}],"structure":"O/C(CCC/C=C\\CCCCCC)=C(C(N1[C@@]2([H])CCC1)=O)/C2=O","databaseIds":["pubchem:146682053","npatlas:NPA024342","chebi:219394"],"moieties":["alkyl side chain","Pyrrolizidine dione"],"cyclic":true,"mass":319.21474,"formula":"C19H29NO3"},{"name":"pyreudione E","evidence":[{"method":"NMR","references":["doi:10.1016/j.chembiol.2018.02.013"]},{"method":"Mass spectrometry","references":["doi:10.1016/j.chembiol.2018.02.013"]},{"method":"Total synthesis","references":["doi:10.1016/j.chembiol.2018.02.013"]}],"classes":["Tetramate alkaloid"],"bioactivities":[{"name":"antibacterial","observed":true,"references":["doi:10.1016/j.chembiol.2018.02.013","doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"12.5 µg/mL","target":"antibacterial"}]},{"name":"antiprotozoal","observed":true,"references":["doi:10.1016/j.chembiol.2018.02.013","doi:10.1021/acschembio.9b00388"],"assays":[{"concentration":"5.7 µg/mL","target":"antiprotozoal"}]}],"structure":"CCCCCCC/C(O)=C1\\C(=O)[C@@H]2CCCCN2C1=O","databaseIds":["pubchem:146684619","npatlas:NPA028502","chebi:219761"],"moieties":["alkyl side chain","Indolizidine dione"],"cyclic":true,"mass":279.18344,"formula":"C16H25NO3"}],"taxonomy":{"name":"Pseudomonas fluorescens","ncbiTaxId":294},"genes":{"annotations":[{"id":"WP_064118616.1","name":"pys","product":"non-ribosomal peptide synthetase"}]},"comment":"The single NRPS is multispecific with regards to amino acid activation (L-proline, L-pipecolic acid) and C starter domain substrate specificity (3-oxo fatty acids of different length and saturation), thereby allowing to form different tetramic acids via Dieckmann-type cyclization. Depending on the amino acid substrate, acyltetramic acids with a pyrrolizidine (A domain substrate: L-proline) or an indolicidine (A domain substrate: L-pipecolic acid) core structure are formed.","legacy_references":["pubmed:27294402","pubmed:29606578","pubmed:31294961"]}